我們已在上線!
進一步了解
ISEE
IVERIC bio, Inc. Common Stock
ISEE
ISEE
已下市
ISEE已於2023年7月10日下市。
關於: IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases, or IRDs.
員工: 163
新聞
正面
中性
負面
市場情緒
3個月
正面
0%
中性
0%
負面
0%
我們尚未收到任何關於ISEE的最新新聞文章。
價格圖表採用Lightweight Charts™實作